These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6931474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
    Viala A, Hou N, Ba B, Durand A, Dufour H, D'Agostino N, Berda C, Jørgensen A.
    Psychopharmacology (Berl); 1984; 83(2):147-50. PubMed ID: 6146995
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fluctuation of serum zuclopenthixol concentrations in patients treated with zuclopenthixol decanoate in viscoleo.
    Poulsen JH, Olesen OV, Larsen NE.
    Ther Drug Monit; 1994 Apr; 16(2):155-9. PubMed ID: 8009563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
    Jørgensen A, Aaes-Jørgensen T, Gravem A, Amthor KF, Dencker SJ, Rosell I, Baastrup PC, Buckhave J, Gram LF.
    Psychopharmacology (Berl); 1985 Apr; 87(3):364-7. PubMed ID: 2867572
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of three different injectable zuclopenthixol preparations.
    Aaes-Jørgensen T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Apr; 13(1-2):77-85. PubMed ID: 2568662
    [Abstract] [Full Text] [Related]

  • 16. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG, Dencker SJ, Gravem A, Remvig J.
    Acta Psychiatr Scand Suppl; 1980 Apr; 279():77-91. PubMed ID: 6996426
    [Abstract] [Full Text] [Related]

  • 17. Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics.
    Dencker SJ, Elgen K.
    Acta Psychiatr Scand Suppl; 1980 Apr; 279():5-9. PubMed ID: 6996425
    [No Abstract] [Full Text] [Related]

  • 18. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
    Dencker SJ, Lepp M, Malm U.
    Acta Psychiatr Scand Suppl; 1980 Apr; 279():10-28. PubMed ID: 6931470
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
    Viala A, Ba B, Durand A, Gouezo F, Hou N, Jørgensen A.
    Psychopharmacology (Berl); 1988 Apr; 94(3):293-7. PubMed ID: 2895936
    [Abstract] [Full Text] [Related]

  • 20. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R, Rajhkowa S.
    Pharmatherapeutica; 1982 Apr; 3(2):93-9. PubMed ID: 7100227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.